3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
3
Thoracic
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Breast
1
Conditions
Carcinoma, Hepatocellular
10
Colorectal Neoplasms
9
Rectal Neoplasms
8
Wilms Tumor
7
Pancreatic Neoplasms
7
Neuroblastoma
7
Lymphoma, Non-Hodgkin
7
Hepatoblastoma
7
Glioma
7
Sarcoma
6
Rhabdomyosarcoma
6
Rhabdoid Tumor
6
Osteosarcoma
6
Neuroectodermal Tumors, Primitive, Peripheral
6
Medulloblastoma
6
Histiocytosis, Langerhans-Cell
6
Ependymoma
6
Lung Neoplasms
5
Central Nervous System Neoplasms
5
Stomach Neoplasms
4
Sarcoma, Ewing
4
Ovarian Neoplasms
4
Esophageal Neoplasms
4
Colonic Neoplasms
4
Melanoma
3
Endometrial Neoplasms
3
Uterine Cervical Neoplasms
2
Prostatic Neoplasms
2
Lymphoma
2
Liver Neoplasms
2
Interventions
Specimen Handling
4
Magnetic Resonance Spectroscopy
3
Nivolumab
2
Biopsy
2
trastuzumab deruxtecan
1
sargramostim
1
rucaparib
1
ribociclib
1
pembrolizumab
1
ceralasertib
1
belinostat
1
X-Rays
1
Tissue Banks
1
Ipilimumab
1
Immunoglobulin G
1
Fulvestrant
1
Fluorouracil
1
Cyclophosphamide
1
Colony-Stimulating Factors
1
Carboplatin
1
CTLA-4 Antigen
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinosarcoma
×
X-Rays
×
Gastrointestinal
×
Clear all
NCT05269381
2026-03-12
PNeoVCA
Mayo Clinic
Phase 1/2
Recruiting
132 enrolled